top of page

Program 

Wednesday 3rd May, 2023

08:00-08:45

08:45-09:30

Registration, Gathering and Exhibition
 

Opening Ceremony- Honored by the President of the State of Israel
                           His Excellency Mr. Isaac Herzog
                           Honored by the presence of the Davidoff Family

09:30-11:15

Session 1

Chairpersons: Dr. Ofir Wolach & Dr. Itai Levi

​

09:30-10:00- How I treat ALL at MD Anderson in 2023
                      Hagop Kantarjian, MD, MD Anderson, Houston, USA

10:00-10:05 -  Q&A
10:05-10:40 - Are we ready for risk-adapted therapy in CML 

                    Timothy Hughes, MD, SAHMRI Beat Cancer, University of Adelaide, Australia

10:40-11:15 - Novel prediction models in cancer associated thrombosis

                      Jeffrey I. Zwicker, MD,Memorial Sloan Kettering Cancer Center, NY, USA

videocamera-icon-png-and-vector-for-free-download-449572.png
Capture.JPG

Coffee Break

11:15-11:45

11:45-12:00

Greetings

Session 2

12:00-13:45

Chairpersons: Dr. Avi Leader & Dr. Tamar Tadmor

12:00-12:35 - Personalized induction strategies for AML

                       Gail J. Roboz, MD, Weill Cornell Medicine, The New York Presbyterian                                 Hospital, New York, USA

12:35-13:10 - Updates in T cell lymphoma with focus on emerging cellular therapies
                       Swaminathan Padmanabhan Iyer, MD, MD Anderson, Houston, USA

13:10-13:45- Present and future of molecular testing in CML

                      Simona Soverini, Ph.D, Alma Mater Studiorum Universita di Bologna, Italy

videocamera-icon-png-and-vector-for-free-download-449572.png

13:45-15:00

Lunch Break & Guided museum tour

15:00-17:20

Session 3

Chairpersons: Dr. Anat Gafter- Gvili & Dr. Luliana Vaxman

15:00-15:35 - Acute lymphoblastic leukemia at a single base resolution

                     Gidi Rechavi, MD, Ph.D, Sheba Cancer Research Center, Tel-Hashomer, Israel

15:35-16:10 - Moving towards personalized therapy for Hodgkin lymphoma

                       Alison Moskowitz, MD, Memorial Sloan Kettering Cancer Center, NY,USA

16:10-16:45 - When not to transplant in ALL?

                       Elias Joseph Jabbour, MD, MD Anderson, Houston, USA

16:45-17:20- Should high risk smoldering myeloma be treated outside of a clinical trial?

                       Morie Gertz, MD, Mayo Clinic, Rochester Minnesota, USA

videocamera-icon-png-and-vector-for-free-download-449572.png
videocamera-icon-png-and-vector-for-free-download-449572.png

17:20-17:30

Closing Remarks

Thursday 4th May, 2023

08:00-08:50

Registration, Gathering and Exhibition

08:50-10:45

Session 4

Chairperson: Dr. Tzila Zuckerman & Dr. Avichai Shimoni

08:50-09:00 - Opening Remarks

09:00-09:35 - HMA/VEN...and then?

                     Richard Stone, MD, Dana Farber, Boston, USA

09:35-10:10 - Dormancy as a mechanism of innate resistance to therapy in myeloid malignancies                             Michael Deininger, MD, Versiti, USA

10:10-10:45 - Ph+ ALL today

                     Robin Foa, MD, "Sapienza" University of Rome, Italy

videocamera-icon-png-and-vector-for-free-download-449572.png

10:45-11:15

Coffee Break

Capture.JPG

11:15-13:00

Session 5

Chairpersons: Dr. Merav Leiba & Dr. Nadav Sarid

11:15-11:50 - From broad to ultra targeted therapeutic approaches in CML: which one is                                best?

                        Delphine Rea, MD, Hôpital Saint Louis, Paris, France

11:50-12:25 - CML treatment discontinuation in clinical practice: how can we ameliorate its                                       feasibility?

                       Giuseppe Saglio, MD, University of Turin, Italy

12:25-13:00- Lymphoma/cellular therapy

                      Loretta Nastoupil, MD, MD Anderson, Houston, USA

​

13:00-14:15

Lunch Break & Guided museum tour

videocamera-icon-png-and-vector-for-free-download-449572.png
videocamera-icon-png-and-vector-for-free-download-449572.png

14:15-17:20

Session 6

Chairpersons: Dr. Moshe Gatt & Dr. Ariel Aviv

14:15-14:50 - Anticoagulant-related bleeding in Cancer

                      Kristen Sanfilippo, MD, Washington University School of Medicine in St. Louis,USA

14:50-15:25 - T-cell lymphoma

                      Steve Horwitz, MD, Memorial Sloan Kettering Cancer Center NY, USA

15:25-16:00 - Advances and remaining challenges for patients with Follicular Lymphoma

                      Gilles Salles, MD, Memorial Sloan Kettering Cancer Center NY, USA

16:00-17:35 - Novel agents in CLL: better sequenced or combined

                      Jan Burger, MD, MD Anderson, Houston, USA

17:35-18:10 - The changing landscape of artificial intelligence applications in Hematology

                      Roni Shouval, MD, Memorial Sloan Kettering Cancer Center NY, USA

​

videocamera-icon-png-and-vector-for-free-download-449572.png
videocamera-icon-png-and-vector-for-free-download-449572.png
videocamera-icon-png-and-vector-for-free-download-449572.png
יאנסן.png

18:10-18:20

Closing Remarks

Friday 5th May, 2023

09:00-12:00- Round Table Symposiums

09:00-10:00- CLL and Plasma Cell Dyscrasias

Participants:

  1. Jan Burger, MD, Houston, USA

  2. Morie Gertz, MD, Rochester, USA

  3. Tamar Tadmor, MD, Haifa, Israel

  4. Iuliana Vaxman, MD, Petah-Tikva, Israel

  5. Gilad Itchaki, MD, Petah-Tikva, Israel \ 

 

10:00--11:00- Chronic Myeloid Leukemia

Participants:

  1. Simona Soverini, Ph.D, Bologna, Italy

  2. Giuseppe Saglio, MD, Turin, Italy

  3. Pia Raanani, MD, Petah- Tikva, Israel

  4. Mr. Giora Sharf, Expert Patient Advocate, Israel

  5. Adi Shacham-Abulafia, MD, Petah- Tikva, Israel

 

11:00-12:00- Acute Leukemia

Participants:

  1. Hagop Kantarjian, MD, Houston, USA

  2. Gail Roboz, MD, New York, USA

  3. Richard Stone, MD, Boston, USA

  4. Robin Foa, MD, Rome, Italy

  5. Ofir Wolach, MD, Petah-Tikva, Israel

​

bottom of page